LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
LivaNova PLC , a market-leading medical technology company, today announced that Marco Dolci intends to retire as President of the Cardiopulmonary Business Unit by December 31, 2023. Dolci will...
Source: marketscreener.com